Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial)
Mahwah, New Jersey | August 19, 2025 – Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce the upcoming launch of Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose […]
GlenmarkPharmaReportsQ4 & FY25 Financialresults
Highlights for FY2025 Mumbai, India, May 23, 2025: Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global pharmaceutical company, today announced its financial results for Q4FY25 ended March 31, 2025. Q4FY25 Results: […]
Glenmark Foundation Leads Fight Against Malnutrition with its Transformative Initiative ‘Meri Poushtik Rasoi’ Season Seven
Over 850 entries from 23 states and 4 union territories highlight the growing reach of this nutrition initiative. Mumbai, India; May 6, 2025:Glenmark Foundation, the Corporate Social Responsibility arm of […]